1-4 of 4
Lukas Peter Frenzel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1 -Mutated AML - the SAL/AMLCG Vincent Trial

Lydia Kretschmer, Leo Ruhnke, Christoph Schliemann, Lars Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, Christoph Schmid, Maher Hanoun, Tim Sauer, Klaus H Metzeler, Kerstin Schäfer-Eckart, Mathias Hänel, Martina Crysandt, Paul Jäger, Stefan W. Krause, Christine Dierks, Stefan Klein, Nadia Maguire, Lukas Peter Frenzel, Veit L. Buecklein, Frank Fiebig, Anna Harig, Christian Thiede, Moritz Middeke, Richard Dillon, Claudia D Baldus, Hubert Serve, Uwe Platzbecker, Karsten Spiekermann, Wolfgang Hiddemann, Martin Bornhäuser, Richard F. Schlenk, Carsten Müller-Tidow, Christoph Röllig
Journal: Blood
Blood (2024) 144 (Supplement 1): 1527.1.
https://doi.org/10.1182/blood-2024-198164
Published: 2024
Journal Articles

Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma

Rebecca Wurm-Kuczera, Khouloud Kouidri, Meng Wang, Salahedine Ali, Shashwat Sahay, David Winkler, Ann-Kristin Leskien, Samixa Pudasaini, Joseph Kauer, Isabelle Krämer, Marcel Teichert, Niklas Gebauer, Ulf Schnetzke, Thomas Weber, Lukas Peter Frenzel, Anna-Carina Hund, Evgenii Shumilov, Mirjeta Berisha, Jakob Daniel Rudzki, Christian W. Scholz, Dimitrios Mougiakakos, Georg Lenz, Gerald Wulf, Martin Schmidt-Hieber, Bastian von Tresckow, Peter Dreger, Martin Dreyling, Oliver Weigert, Naveed Ishaque, Ulrich Keller, Christiane Pott, Thomas Oellerich, Björn Chapuy
Journal: Blood
Blood (2024) 144 (Supplement 1): 6494.
https://doi.org/10.1182/blood-2024-200002
Published: 2024
Journal Articles

Venetoclax May Overcome the Prognostic Disadvantage of Short Telomeres Regarding Progression Free Survival in Previously Untreated CLL Patients with Coexisting Conditions: A Study By the German CLL Study Group (GCLLSG)

Lukas Peter Frenzel, Laura Beckmann, Sandra Robrecht, Can Zhang, Anna Maria Fink, Othman Al-Sawaf, Christof Schneider, Brenda Chyla, Hyun Yong Jin, Yanwen Jiang, Tim H. H. Brummendorf, Michael Hallek, Barbara F. Eichhorst, Kirsten Fischer, Fabian Beier, Susanne Isfort
Journal: Blood
Blood (2024) 144 (Supplement 1): 3250.
https://doi.org/10.1182/blood-2024-200075
Published: 2024
Journal Articles

New Suitable Eµ-Tcl1 Mouse Model for Research on BH3-Mimetics Therapy Response In Vivo

Ismini Halmer, Laura Beckmann, Gero Knittel, Hamid Kashkar, Hans Christian Reinhardt, Michael Hallek, Alexandra Da Palma Guerreiro, Lukas Peter Frenzel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1454.
https://doi.org/10.1182/blood-2023-186330
Published: 2023